EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) will participate in a series of high-profile investor conferences this November and December, offering shareholders and analysts a closer look at the company’s strategic direction amid ongoing global demand for injectable drug delivery solutions.
Executives from the Exton-based manufacturer are scheduled to appear at four major events: the UBS Global Healthcare Conference in Palm Beach Gardens, Florida, on November 11; the Jefferies Global Healthcare Conference in London on November 18; the Stephens Annual Investment Conference in Nashville on November 20; and the Citi Global Healthcare Conference in Miami on December 2. Each appearance will feature a fireside chat with West leadership.
The company plans to webcast all sessions live via its investor relations website, with replays available for 90 days following each event.
West, a long-standing supplier of advanced packaging and delivery systems for injectable medications, reported $2.89 billion in net sales for fiscal year 2024. With more than 10,000 employees across 50 sites and 25 manufacturing facilities worldwide, the firm produces over 41 billion components and devices annually.
Traded on the New York Stock Exchange and included in the S&P 500 index, West continues to position itself as a global leader in pharmaceutical containment and delivery technologies, serving both established and emerging drug manufacturers seeking safe and efficient patient solutions.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.